Department of Endocrinology and Metabolism, Faculty of Medicine, Ondokuz Mayis University, 55200, Atakum Samsun, Turkey.
Department of Pathology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Endocr Pathol. 2024 Sep;35(3):185-193. doi: 10.1007/s12022-024-09819-y. Epub 2024 Jul 24.
Unlike somatotroph tumors, the data on correlates of tumor granulation patterns in functional TPIT lineage pituitary neuroendocrine tumors (corticotroph tumors) have been less uniformly documented in most clinical series. This study evaluated characteristics of 41 well-characterized functional corticotroph tumors consisting of 28 densely granulated corticotroph tumors (DGCTs) and 13 sparsely granulated corticotroph tumors (SGCTs) with respect to preoperative clinical and radiological findings, tumor proliferative activity (including mitotic count and Ki-67 labeling index), and postoperative early biochemical remission rates. The median (interquartile range (IQR)) tumor size was significantly larger in the SGCT group [16.00 (16.00) mm in SGCT vs 8.5 (9.75) mm in DGCT, p = 0.049]. T2-weighted signal intensity and T2 intensity (quantitative) did not yield statistical significance based on tumor granulation; however, the T2 intensity-to-white matter ratio was significantly higher in SGCTs (p = 0.049). The median (IQR) Ki-67 labeling index was 2.00% (IQR 1.00%) in the DGCT group and 4.00% (IQR 7.00%) in the SGCT group (p = 0.043). The mitotic count per 2 mm was higher in the SGCT group (p = 0.001). In the multivariate analysis, the sparse granulation pattern (SGCT) remained an independent predictor of a lower probability of early biochemical remission irrespective of the tumor size and proliferative activity (p = 0.012). The current study further supports the impact of tumor granulation pattern as a biologic variable and warrants the detailed histological subtyping of functional corticotroph tumors as indicated in the WHO classification of pituitary neuroendocrine tumors. More importantly, the assessment of the quantitative T2 intensity-to-white matter ratio may serve as a preoperative radiological harbinger of SGCTs.
与生长激素细胞瘤不同,在大多数临床系列中,有关功能性 TPIT 谱系垂体神经内分泌肿瘤(促皮质素细胞瘤)肿瘤颗粒模式相关因素的数据记录得并不那么统一。本研究评估了 41 例特征明确的功能性促皮质素细胞瘤的特征,这些肿瘤包括 28 例致密颗粒促皮质素细胞瘤(DGCT)和 13 例稀疏颗粒促皮质素细胞瘤(SGCT),涉及术前临床和影像学表现、肿瘤增殖活性(包括有丝分裂计数和 Ki-67 标记指数)以及术后早期生化缓解率。SGCT 组的肿瘤大小中位数(四分位距(IQR))明显更大[SGCT 为 16.00(16.00)mm,DGCT 为 8.5(9.75)mm,p=0.049]。基于肿瘤颗粒,T2 加权信号强度和 T2 强度(定量)没有统计学意义;然而,SGCTs 的 T2 强度与白质比显著更高(p=0.049)。DGCT 组的 Ki-67 标记指数中位数(IQR)为 2.00%(IQR 1.00%),SGCT 组为 4.00%(IQR 7.00%)(p=0.043)。SGCT 组每 2mm 的有丝分裂计数更高(p=0.001)。在多变量分析中,稀疏颗粒模式(SGCT)仍然是早期生化缓解概率较低的独立预测因素,与肿瘤大小和增殖活性无关(p=0.012)。本研究进一步支持肿瘤颗粒模式作为生物学变量的影响,并支持根据世界卫生组织垂体神经内分泌肿瘤分类对功能性促皮质素细胞瘤进行详细的组织学亚型分类。更重要的是,定量 T2 强度与白质比的评估可能成为 SGCT 的术前影像学标志物。